Clinical assessment of upper limb impairments and functional capacity in Parkinson's disease: a systematic review
Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Autores
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.81, n.11, p.1008-1015, 2023
Resumo
Background Parkinson's disease (PD) may progressively reduce the upper limb's functionality. Currently, there is no standardized upper limb functional capacity assessment in PD in the rehabilitation field.Objective To identify specific outcome measurements to assess upper limbs in PD and access functional capacity.Methods We systematically reviewed and analyzed the literature in English published from August/2012 to August/2022 according to PRISMA. The following keywords were used in our search: ""upper limbs"" OR ""upper extremity"" and ""Parkinson's disease."" Two researchers searched independently, including studies accordingly to our inclusion and exclusion criteria. Registered at PROSPERO CRD42021254486.Results We found 797 studies, and 50 were included in this review ( n = 2.239 participants in H&Y stage 1-4). The most common upper limbs outcome measures found in the studies were: (i) UPDRS-III and MDS-UPDRS to assess the severity and progression of PD motor symptoms (tremor, bradykinesia, and rigidity) (ii) Nine Hole Peg Test and Purdue Pegboard Test to assess manual dexterity; (iii) Spiral test and Funnel test to provoke and assess freezing of upper limbs; (iv) Technology assessment such as wearables sensors, apps, and other device were also found.Conclusion We found evidence to support upper limb impairments assessments in PD. However, there is still a large shortage of specific tests to assess the functional capacity of the upper limbs. The upper limbs' functional capacity is insufficiently investigated during the clinical and rehabilitation examination due to a lack of specific outcome measures to assess functionality.
Palavras-chave
Parkinson Disease, Upper Extremity, Physical Therapy Modalities, Treatment Outcome, Rehabilitation, Freezing
Referências
- Abbruzzese G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00961
- Allen NE, 2017, PARKINSONISM RELAT D, V41, P66, DOI 10.1016/j.parkreldis.2017.05.011
- [Anonymous], 2022, CLIN ASS MAN BAL IMP, P168
- Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360
- Bloem BR, 2021, LANCET, V397, P2284, DOI 10.1016/S0140-6736(21)00218-X
- Bloem BR, 2016, MOVEMENT DISORD, V31, P1342, DOI 10.1002/mds.26572
- Broeder S, 2019, HUM MOVEMENT SCI, V65, P142, DOI 10.1016/j.humov.2018.02.012
- Cabrera-Martos I, 2019, CLIN REHABIL, V33, P465, DOI 10.1177/0269215518815217
- Capato T T., 2019, PARKINSONISM RELAT D
- Capato TTdC, 2015, DOM JMM AL LRS, P1
- Cavallo F, 2019, PARKINSONISM RELAT D, V63, P111, DOI 10.1016/j.parkreldis.2019.02.028
- Chan PY, 2018, IEEE T NEUR SYS REH, V26, P460, DOI 10.1109/TNSRE.2017.2782361
- Cikajlo I, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0601-1
- David FJ, 2016, J NEUROPHYSIOL, V116, P2298, DOI 10.1152/jn.01067.2015
- de Freitas PR, 2017, J HAND THER, V30, P320, DOI 10.1016/j.jht.2016.07.003
- Delval A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181973
- Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3
- Eggers C, 2015, J NEUROL, V262, P357, DOI 10.1007/s00415-014-7572-8
- Espay AJ, 2018, JAMA NEUROL, V75, P1132, DOI 10.1001/jamaneurol.2018.1264
- Fahn S., 1987, RECENT DEV PARKINSON, P153
- Fahn S., 1993, CLIN RATING SCALE TR, V2, P271
- Fox SH, 2018, MOVEMENT DISORD, V33, P1992, DOI 10.1002/mds.27548
- França C, 2018, BRAIN STIMUL, V11, P249, DOI 10.1016/j.brs.2017.11.015
- Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198
- Heideman SG, 2015, CLIN NEUROPHYSIOL, V126, P348, DOI 10.1016/j.clinph.2014.04.020
- Heremans E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142874
- Jansen AE, 2021, PARKINSONISM RELAT D, V93, P103, DOI 10.1016/j.parkreldis.2021.11.004
- Janzen TB, 2019, HUM MOVEMENT SCI, V64, P355, DOI 10.1016/j.humov.2019.03.001
- Jitkritsadakul O, 2017, J NEUROL SCI, V381, P331, DOI 10.1016/j.jns.2017.08.3246
- Jo HJ, 2016, CLIN NEUROPHYSIOL, V127, P684, DOI 10.1016/j.clinph.2015.05.023
- Keus S., 2014, EUROPEAN PHYSIOTHERA
- Knippenberg E, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0270-x
- Kueper JK, 2017, AGE AGEING, V46, P729, DOI 10.1093/ageing/afx084
- Lora-Millan JS, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.700600
- Mateos-Toset S, 2016, PM&R, V8, P115, DOI 10.1016/j.pmrj.2015.06.004
- Memedi M, 2013, SENSORS-BASEL, V13, P16965, DOI 10.3390/s131216965
- Messa LV, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00350
- Mittal SO, 2020, TREMOR OTHER HYPERK, V10, DOI 10.5334/tohm.582
- Moher D, 2010, INT J SURG, V8, P336, DOI [10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]
- Momin S, 2018, J PARKINSON DIS, V8, P267, DOI 10.3233/JPD-171150
- Moumdjian L, 2017, EUR J PHYS REHAB MED, V53, P466, DOI 10.23736/S1973-9087.16.04429-4
- Ospina BM, 2018, J PARKINSON DIS, V8, P563, DOI 10.3233/JPD-181401
- Ni M, 2016, COMPLEMENT THER MED, V25, P126, DOI 10.1016/j.ctim.2016.01.007
- Ni M, 2016, ARCH PHYS MED REHAB, V97, P345, DOI 10.1016/j.apmr.2015.10.095
- Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x
- Nowinski CJ, 2016, MOVEMENT DISORD, V31, P725, DOI 10.1002/mds.26546
- Osborne JA, 2022, PHYS THER, V102, DOI 10.1093/ptj/pzab302
- Page MJ, 2022, REV PANAM SALUD PUBL, V46, DOI [10.1186/s13643-021-01626-4, 10.26633/RPSP.2022.112, 10.1371/journal.pmed.1003583, 10.1016/j.rec.2021.07.010, 10.1016/j.jclinepi.2021.03.001, 10.1016/j.ijsu.2021.105906, 10.1136/bmj.n71]
- Park JK, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910095
- Paul SS, 2020, BEHAV BRAIN RES, V377, DOI 10.1016/j.bbr.2019.112213
- Pazzaglia C, 2020, PHYSIOTHERAPY, V106, P36, DOI 10.1016/j.physio.2019.12.007
- Picelli A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-28
- Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424
- Pradhan S, 2015, PHYS THER, V95, P369, DOI 10.2522/ptj.20130570
- Proud E, 2021, DISABIL REHABIL, V43, P3834, DOI 10.1080/09638288.2020.1754474
- Proud EL, 2015, ARCH PHYS MED REHAB, V96, P540, DOI 10.1016/j.apmr.2014.09.016
- Proud EL, 2013, PHYSIOTHER CAN, V65, P309, DOI 10.3138/ptc.2012-24
- Ryan D, 2021, ARCH REHAB RES CLIN, V3, DOI 10.1016/j.arrct.2021.100106
- Saba RA, 2022, ARQ NEURO-PSIQUIAT, V80, P316, DOI [10.1590/0004-282X-ANP-2021-0219, 10.1590/0004-282x-anp-2021-0219]
- Samotus O, 2022, TOXINS, V14, DOI 10.3390/toxins14080557
- Samotus O, 2018, TOXINS, V10, DOI 10.3390/toxins10100394
- Samotus O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178670
- Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874
- Sherrington C, 2000, MANUAL THER, V5, P223, DOI 10.1054/math.2000.0372
- Simpson MW, 2020, J NEUROL, V267, P3479, DOI 10.1007/s00415-019-09385-y
- Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006
- Sterling NW, 2015, J PARKINSON DIS, V5, P141, DOI 10.3233/JPD-140447
- Sturkenboom IHWM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-34
- van den Noort JC, 2017, ANN BIOMED ENG, V45, P2423, DOI 10.1007/s10439-017-1881-x
- Vanbellingen T, 2017, PARKINSONISM RELAT D, V41, P92, DOI 10.1016/j.parkreldis.2017.05.021
- Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015
- Vingerhoets FJG, 1997, ANN NEUROL, V41, P58, DOI 10.1002/ana.410410111
- Williams AJ, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/595378
- Zetterberg H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/276182